Firefly Neuroscience Stock Continues To Climb: What's Going On?

Comments
Loading...
Zinger Key Points

Firefly Neuroscience Inc AIFF shares are continuing to trade higher Wednesday after rallying more than 170% on Tuesday. Here’s a look at what’s going on.

What To Know: Firefly Neuroscience shares soared on Tuesday after the company was accepted into the NVIDIA Connect program. The stock appears to be moving on continued momentum Wednesday morning.

Firefly expects to use new tools and resources provided by the program to help support a new strategic initiative to build a proprietary foundation model of the human brain using its FDA-cleared Brain Network Analytics technology platform.

Nvidia’s Connect program helps companies expand software development teams by providing software development resources, frameworks and development kits. Benefits include technical training, engineering guidance and discounts on Nvidia software and hardware products.

See Also: Inflation Rises More Than Expected In January, Chills Interest Rate Cut Hopes

“This marks the achievement of an important milestone for Firefly and comes at an extremely opportune time,” said Greg Lipschitz, executive chairman of Firefly Neuroscience.

Firefly is due to report fourth-quarter financial results later this month.

AIFF Price Action: Firefly Neuroscience shares closed Tuesday up 171%. The stock was up another 48.6% at $12.48 at the time of publication Wednesday, according to Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

AIFF Logo
AIFFFirefly Neuroscience Inc
$3.02-2.27%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
-
Growth
-
Quality
-
Value
3.01
Price Trend
Short
Medium
Long
Got Questions? Ask
Which biotech companies could replicate Firefly's success?
How will NVIDIA's Connect program impact industry dynamics?
What other firms might benefit from NVIDIA's resources?
Could Firefly's technology attract partnerships?
What impact will FDA clearance have on biotech investments?
How might AI advancements reshape the healthcare sector?
What are the implications for neuroscience research funding?
Which investors are most likely to support Firefly's initiatives?
How could market sentiment shift after Firefly's earnings report?
What competitive edge does Firefly's model provide?
Market News and Data brought to you by Benzinga APIs

Posted In: